posted on 2016-06-20, 13:44authored byVivien Landré, Alexey Antonov, Richard Knight, Gerry Melino
Glioblastoma Multiforme is one of the most highly metastatic cancers and constitutes 70% of all gliomas. Despite aggressive treatments these tumours have an exceptionally bad prognosis, mainly due to therapy resistance and tumour recurrence. Here we show that the transcription factor p73 confers an invasive phenotype by directly activating expression of POSTN (periostin, HGNC:16953) in glioblastoma cells. Knock down of endogenous p73 reduces invasiveness and chemo-resistance, and promotes differentiation in vitro. Using chromatin immunoprecipitation and reporter assays we demonstrate that POSTN, an integrin binding protein that has recently been shown to play a major role in metastasis, is a transcriptional target of TAp73. We further show that POSTN overexpression is sufficient to rescue the invasive phenotype of glioblastoma cells after p73 knock down. Additionally, bioinformatics analysis revealed that an intact p73/ POSTN axis, where POSTN and p73 expression is correlated, predicts bad prognosis in several cancer types. Taken together, our results support a novel role of TAp73 in controlling glioblastoma cell invasion by regulating the expression of the matricellular protein POSTN.
Funding
This work has been supported by the Medical
Research Council, UK; grants from Associazione Italiana
per la Ricerca contro il Cancro (AIRC; 2011-IG11955;
5xmille MCO #9979) and Fondazione Roma (NCD), Min.
Salute to Istituto Dermopatico dell’Immacolata/Istituto di
Ricovero e Cura a Carattere Scientifico (IDI-IRCCS RF08
c.15, RF07 c.57) to GM.